ArticleDrug design, development and therapy2022

Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway.

Hong Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.